Midatech Pharma Shs Sponsored American Deposit Receipt Repr 2 Shs (NASDAQ:MTP)
Industry: Healthcare

OFF LIST - 2212 consecutive market days: OFF LIST as of 08/22/2007 Through 11/14/2016

Midatech Pharma PLC, a specialty pharmaceutical company, focuses on the development and commercialization of oncology and other therapeutic products in the United Kingdom, Turkey, other European countries, and the United States. It offers Oravig, an orally dissolving buccal tablet for oral thrush and oropharyngeal candidiasis in adults; Gelclair, an oral rinse gel for the management and relief of pain arising from oral lesions of various etiologies; Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; and Soltamox, an oral liquid solution of tamoxifen citrate for the prevention of breast cancer. The company also engages in the marketing of Ferralet 90, a prescription iron supplement for the treatment of anemias that are responsive to oral iron therapy; and Aquoral, an artificial saliva spray to provide relief from chemotherapy/radiation therapy. In addition, it is involved in the research and development of various product candidates in the areas of oncology and neuroscience, including ophthalmology; and immunotherapy. Midatech Pharma PLC was founded in 2000 and is headquartered in Abingdon, the United Kingdom.

Current Quote*
Last: $1.260
Change: -0.060
Book: $Unk
Volume: 20,069

As Of: 01/17 16:16 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol MTP

Graphs for MTP


3 Month Graph


6 Month Graph


1 Year Graph